Top pick for banking + investing in one app
- Trade stocks, options, ETFs and mutual funds
- Access to a financial planner
- All-in-one app for banking and investing
- Automated investing available
The best medical supplies stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
The top health stocks included on this page all trade on the S&P 500, have an analyst recommendation of "Buy" or better and are sorted by year-to-date performance.
Top pick for banking + investing in one app
Top pick for copy trading
Get 12 free shares
The Cooper Companies, Inc. , together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
The Cooper Companies stock opened the day at $62.83 after a previous close of $62.19. The latest price was $62.65 (25-minute delay). The Cooper Companies is listed on the NASDAQ, has a trailing 12-month revenue of around USD4.2 billion and employs 15,000 staff.
Baxter International Inc. , through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Baxter International stock opened the day at $25.90 after a previous close of $25.65. The latest price was $25.81 (25-minute delay). Baxter International is listed on the NYSE, has a trailing 12-month revenue of around USD$11.6 billion and employs 37,500 staff.
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
Hologic stock opened the day at $76.01 after a previous close of $76.01. The latest price was $76.01 (25-minute delay). Hologic is listed on the NASDAQ, has a trailing 12-month revenue of around USD$4.1 billion and employs 7,070 staff.
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
Dentsply Sirona stock opened the day at $0.00 after a previous close of $9.24. The latest price was $0.00 (25-minute delay). Dentsply Sirona is listed on the NASDAQ, has a trailing 12-month revenue of around USD$3.6 billion and employs 14,000 staff.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters.
Teleflex Incorporated stock opened the day at $0.00 after a previous close of $0.00. The latest price was $0.00 (25-minute delay). Teleflex Incorporated is listed on the NYSE, has a trailing 12-month revenue of around USD$2.3 billion and employs 15,500 staff.
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.
ResMed stock opened the day at $234.00 after a previous close of $235.30. The latest price was $235.30 (25-minute delay). ResMed is listed on the NYSE, has a trailing 12-month revenue of around USD$5.7 billion and employs 11,370 staff.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
Intuitive Surgical stock opened the day at $0.00 after a previous close of $0.00. The latest price was $0.00 (25-minute delay). Intuitive Surgical is listed on the NASDAQ, has a trailing 12-month revenue of around USD$11.6 billion and employs 17,021 staff.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care.
Alcon stock opened the day at $73.06 after a previous close of $72.46. The latest price was $71.83 (25-minute delay). Alcon is listed on the NYSE, has a trailing 12-month revenue of around USD$10.9 billion and employs 25,000 staff.
Check out Finder's picks for the best brokerage accounts
Compare top brokerage accounts and apps to help you maximize your investment.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Seven brokers open IPO share requests to retail investors — but minimums, odds and flipping rules vary sharply.
Our top 10 beginner-friendly stocks and ETFs, and why we picked them — plus 7 more.
Discover the best robo-advisors of 2026. Compare fees, account minimums and features from top platforms that automate investing for beginners and pros.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
We’ve rounded up stats on some of the most popular oil stocks, along with information on how they compare and how to invest.
Six stocks that cleared our November 2026 screen for quality, growth and balance-sheet strength.
What to consider before you invest in biotechnology companies.
Copper is an industrial metal with many applications. Here’s what you should consider before investing.
Top stocks and ETFs to consider for those ready to invest in cannabis.
Here’s what a blue chip stock is, including examples, as well as what makes it attractive to investors and how to buy and sell them.
Finder is a comparison platform and information service designed to help you make better decisions. To keep our service free, we receive compensation from the companies whose products or services we feature on our site.
We may be paid when you click on a link, submit an application, or open an account.
Our commercial arrangements affect which products we write about, as well as the inclusion, order, position and placement of products on our site. They do not influence our independent assessments or editorial views, which are based on research and expert analysis conducted by our editorial team.
The inclusion of a provider or product in our content, or the order in which products appear in tables or lists, is not an endorsement or recommendation from us.
We compare a wide range of products, providers and services, but we don't cover the whole market. Not every company or offer available is included on our site, and other options may be available to you.
The information we provide is general in nature and is not financial, investment, tax or legal advice. Consider your own circumstances and read the provider's terms and conditions before making a decision.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.